UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014436
Receipt number R000016797
Scientific Title The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion.
Date of disclosure of the study information 2014/07/01
Last modified on 2014/07/01 00:40:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion.

Acronym

The study of treatment and prognosis for AMD

Scientific Title

The clinical study associated with the treatment effects and effectiveness prediction of subretinal neovascularization lesion.

Scientific Title:Acronym

The study of treatment and prognosis for AMD

Region

Japan


Condition

Condition

Age-related Macular Degeneration

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To assess clinical factors for selecting optionally treatment modalities of AMD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Visual acuity and central retinal thickness before and after each treatment.

Key secondary outcomes

Disease type and history of ophthalmic treatment and systemic factors.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with age-related macular degeneration.

Key exclusion criteria

Patients who disagreed with this study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidetoshi Yamashita

Organization

Yamagata University Faculty of Medicine

Division name

Department of Ophthalmology and Visual Sciences

Zip code


Address

2-2-2 Iidanishi, Yamagata

TEL

023-628-5374

Email

hyama-tky@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takanori Murakami

Organization

Yamagata University Faculty of Medicine

Division name

Department of Ophthalmology and Visual Sciences

Zip code


Address

2-2-2 Iidanishi Yamagata

TEL

023-628-5047

Homepage URL


Email

ikekenkyu@jm.kj.yamagata-u.ac.jp


Sponsor or person

Institute

Department of Ophthalmology and Visual Sciences Yamagata

Institute

Department

Personal name



Funding Source

Organization

Department of Ophthalmology and Visual Sciences Yamagata University Faculty of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山形大学医学部附属病院(山形県)/Yamagata University Hospital


Other administrative information

Date of disclosure of the study information

2014 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 05 Month 19 Day

Date of IRB


Anticipated trial start date

2014 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will assess outcomes of treatment about subretinal neovascularization lesion.


Management information

Registered date

2014 Year 07 Month 01 Day

Last modified on

2014 Year 07 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016797


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name